Allergic Rhinitis Market Forecast To Reach $19.58 Billion By 2030: Key Growth Drivers And Industry Trends
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Allergic Rhinitis Market CAGR Outlook And Future Development
The allergic rhinitis market size has shown consistent expansion in recent years. It is projected to increase from $15.69 billion in 2025 to $16.28 billion in 2026, reflecting a compound annual growth rate (CAGR) of 3.8%. This historical growth can be attributed to factors such as increasing awareness of allergies, rising exposure to environmental allergens, the adoption of traditional antihistamines and corticosteroids, the growth of hospital pharmacy networks, and the development of diagnostic skin testing methods.
The allergic rhinitis market is anticipated to experience consistent growth over the coming years. Its value is projected to reach $19.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is attributable to improvements in immunotherapy treatments, a growing need for personalized allergy management, the increasing acceptance of online pharmacies, technological advancements in IgE RAST and blood tests, and the expansion of global allergy treatment markets. Prominent trends for the forecast period include the rising worldwide prevalence of allergic rhinitis, greater utilization of immunotherapy and personalized treatments, the increasing adoption of nasal corticosteroids and antihistamines, the spread of online pharmacies and e-commerce distribution, and enhanced diagnostic testing, including skin and IgE RAST tests.
Get A Free Sample Report With In-Depth Market Insights:
Allergic Rhinitis Market Industry Drivers: What’s Behind The Revenue Growth?
Elevated air pollution and climate change are anticipated to fuel the expansion of the allergic rhinitis market in the coming period. Air pollution signifies the existence of detrimental substances in the Earth’s atmosphere that can negatively impact human health, the environment, and the breathability of the air. Climate change refers to long-term transformations in the Earth’s climatic patterns, including temperature, precipitation, and other meteorological elements. Air pollution is increasingly identified as a critical environmental factor contributing to the occurrence and intensification of allergic rhinitis, emphasizing the intricate connection between air quality and respiratory health. For instance, in August 2024, as per the United States Environmental Protection Agency, a US-based Government agency, around 66 million tons of pollutants were discharged into the atmosphere across the United States in 2023. Thus, significant levels of air pollution and climate change propel the allergic rhinitis market.
Allergic Rhinitis Market Segment Trends And Revenue Contributors
The allergic rhinitis market covered in this report is segmented –
1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis
2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments
3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test
4) By Route Of Administration: Oral, Nasal, Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores
Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens
#Allergic Rhinitis Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the allergic rhinitis market are concentrating on creating innovative products, such as combination allergy therapies, to enhance multi-pathway symptom relief and improve the long-term management of allergic conditions. These combination therapies represent dual-action formulations, integrating different classes of active ingredients to deliver broader and more effective control over allergy-related inflammation. For instance, in October 2025, Cadila Pharmaceuticals, an India-based pharmaceutical manufacturer, launched Dlorfast-M Tablets. This particular formulation pairs Desloratadine and Montelukast to block both histamine- and leukotriene-mediated pathways, providing stronger and more comprehensive relief than either agent alone. The once-daily dosing of this product improves treatment adherence and broadens therapeutic options for patients experiencing allergic rhinitis and urticaria.
Allergic Rhinitis Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company plc, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd.
View The Full Allergic Rhinitis Market Report:
Allergic Rhinitis Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the allergic rhinitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allergic rhinitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
